| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Corresponding author: Daniel E. Gottschling, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. North, MS A3-025, Seattle, WA 98109-1024., dgottsch{at}fhcrc.org (E-mail)
Communicating editor: L. PILLUS
| ABSTRACT |
|---|
Telomeres are the protective ends of linear chromosomes. Telomeric components have been identified and described by their abilities to bind telomeric DNA, affect telomere repeat length, participate in telomeric DNA replication, or modulate transcriptional silencing of telomere-adjacent genes; however, their roles in chromosome end protection are not as well defined. We have developed a genetic, quantitative assay in Saccharomyces cerevisiae to measure whether various telomeric components protect chromosome ends from homologous recombination. This "chromosomal cap" assay has revealed that the telomeric end-binding proteins, Cdc13p and Ku, both protect the chromosome end from homologous recombination, as does the ATM-related kinase, Tel1p. We propose that Cdc13p and Ku structurally inhibit recombination at telomeres and that Tel1p regulates the chromosomal cap, acting through Cdc13p. Analysis with recombination mutants indicated that telomeric homologous recombination events proceeded by different mechanisms, depending on which capping component was compromised. Furthermore, we found that neither telomere repeat length nor telomeric silencing correlated with chromosomal capping efficiency. This capping assay provides a sensitive in vivo approach for identifying the components of chromosome ends and the mechanisms by which they are protected.
THE work of H. J. Muller and Barbara McClintock defined telomeres as the protective ends of linear chromosomes. Muller coined the term "telomere" as he observed that X-ray-induced chromosomal inversions, fusions, and translocations in Drosophila never involved chromosome ends (![]()
![]()
![]()
![]()
![]()
The ends of most eukaryotic linear chromosomes terminate in telomeric DNA, repeats of 525 bp that vary in sequence among species and end in a 3' single-stranded overhang (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
The protection of the chromosome end arguably depends on the structure of the telomeric terminusthe absolute end of the chromosome. Many studies involving telomere biochemistry, telomeric length maintenance, and the transcriptional silencing of telomere-adjacent genes have identified several components that contribute to telomeric structure (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
In other species, structural details of the molecular interactions between telomere-binding proteins and the telomeric DNA repeats have been characterized. Ciliated protozoa have a heterodimeric protein complex that envelops the macronuclear chromosomal DNA end (![]()
![]()
![]()
![]()
![]()
Several telomeric proteins are conserved evolutionarily: The TRF proteins are related to the fission yeast Schizosaccharomyces pombe telomere-binding protein Taz1 (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Several in vivo assays have addressed whether a telomere is protected or "capped," but they have led to different definitions of what constitutes a cap. Many assays have simply reflected the need for telomeric DNA repeats at the end of the chromosome. For instance, telomeres in telomerase-negative strains are said to be uncapped because the telomeric repeats continually shorten and can lead to end-to-end fusions (![]()
![]()
![]()
The possible "capping" functions of some of the aforementioned telomeric components have been investigated. For example, deletion of either of the telomere-binding protein genes taz1+ or pot1+ in S. pombe leads to end-to-end fusions between telomeres (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Telomere capping also has been inferred by recombination assays. For example, a gradient of mitotic recombination that is highest near the telomere is observed in S. cerevisiae strains with a cdc13-1 mutation (![]()
![]()
![]()
![]()
![]()
To better understand how chromosome ends are capped, we took advantage of the strengths of S. cerevisiae to develop an in vivo assay that would be amenable to evaluating one aspect of end protection at a time and be quantitative in nature. Furthermore we sought that it be adaptable for use in a genetic screen to identify additional factors that participate in the chromosomal cap or its regulation. The genetic assay we have developed quantitatively measures the ability of native chromosome ends to be protected from homologous recombination.
| MATERIALS AND METHODS |
|---|
Plasmid and DNA manipulations:
The following fragments were PCR amplified and used in the construction of the artificial chromosomes. The "HIS3 end" was PCR amplified from pHIS3.2000.TEL(+) with oligos lam-his-1 (YE4b
T sequence in uppercase letters and HIS3 sequence in lowercase: AGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCGgcctcggtaatgattttcat) and lam-his-2 (CGAATTCCCCCTGCCACCAC) to generate an
3.4-kb fragment. pHIS3.2000.TEL(+) was constructed by S. Diede by inserting the 2-kb HpaI fragment from
DNA into the NruI site of pAKHIS3.14. pAKHIS3.14 also was created by S. Diede by ligating a HIS3 PCR fragment into the blunted BglII and HindIII sites of pVZ1 (![]()
![]()
The "URA3 fragment" was PCR amplified from pRS306 (![]()
pSD243 was constructed by S. Diede from a ligation of the BglII/SpeI blunted fragment with MET15 from pGC3 (![]()
![]()
plasmid; ![]()
Oligos HOint1 (artificial chromosome sequence upstream of ARS1 in uppercase and pMET-HO-TELO sequence in lowercase: GTGAAGGAGCATGTTCGGCACACAGTGGACCGAACGTGGGcaaatggcacgtgaagctgtc) and HOint2 (artificial chromosome sequence downstream of TRP1 in uppercase and pMET-HO-TELO sequence in lowercase: GTCTGTTATTAATTTCACAGGTAGTTCTGGTCCATTGGTGcagctcattttttaaccaataggc) were used to PCR amplify both the "MET-HO-TG" fragment from pMET-HO-TELO and the "MET-HO" fragment from pMET-HO.
Yeast methods and strain construction:
Rich (YEP) and synthetic complete yeast (YC) media have been described (![]()
![]()
The artificial chromosome YE4b
T from R. Wellinger (![]()
![]()
![]()
sequence by transformation with the "HIS3 end" (below) to create UCC2249. UCC2249 was transformed with the "URA3 fragment" to create UCC2301, which has the URA3 gene inserted between ade3-2p and CEN4. UCC2301 was transformed with the "MET-HO-TG" fragment, and this artificial chromosome was transformed into UCC5843 to create UCC2311 and UCC2313 (two independent transformants). Similarly the "MET-HO" fragment was transformed into UCC2301, and then this artificial chromosome was transferred into UCC5843 to create UCC2317 and UCC2319 (two independent transformants). The "MET-HO-TG" (A) and the "MET-HO" (C) fragments replace the ARS1-TRP1 regions of YE4b
T, resulting in the final set of artificial chromosomes (
65 kb each). Strains UCC2311, UCC2313, UCC2317, and UCC2319 were then mated with YPH925 (a kar1 strain; ![]()
All wild-type and single-mutant strains used in the assays (Table 1) are MATa-inc strains (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
|
All double-mutant strains were constructed by sporulation of diploids that were heterozygous for the mutations of interest (Table 2). The diploids were created from matings of single-mutant haploid strains, all of which were derived from UCC2325, UCC2326, or UCC2327.
|
Telomere capture assays:
The following steps were performed with each yeast strain (wild type or mutant) shown in Fig 3 and Fig 4. To transfer the artificial chromosomes into each of these strains, two transformants (or two independent spores of each of the double-mutant strains) of each of these yeast strains were mated with four different kar1 strains (![]()
![]()
|
|
|
|
Statistical analysis:
The data for each strain as generated by the assay are summarized for both homologous recombination and NHEJ capture events in Table 3. Median frequencies of capture events were determined for all strains. [Rates of capture events were not calculated because the underlying assumptions of computing rates from frequency measurements, as in a fluctuation analysis (![]()
![]()
4 x 10-8) is close to the average frequency of several strains, these strains showed one or more isolates that had no capture events ("% with no events" in Fig 3 and Fig 4). The P values for pairwise comparisons between wild-type and mutant strain (shown in Table 3) and other pairs of mutant strains are generated using the Wilcoxon rank-sum test. Group comparisons were done using one-way ANOVA. Prism (Graphpad Software) was used to generate Fig 3 and Fig 4.
|
Molecular biology techniques:
Agarose gels were blotted onto Hybond N+ nylon membranes (Amersham, Buckinghamshire, UK) in 0.4 M NaOH, 1.5 M NaCl for >4 hr. Blots were probed with a digoxigenin-labeled Y' fragment (![]()
![]()
Agarose-embedded DNA plugs, pulsed-field gel electrophoresis, and Southern blotting of contour-clamped homogeneous electric field (CHEF) gels were done according to the manufacturer's instructions (Bio-Rad; model CHEF-DRII). Gels were run at 6 V/cm for 27 hr with 7- to 170-sec switch times and alkaline blotted as above for
24 hr.
Y' PCR experiments used one primer within the Y' element (Y'XhoI: GATACGGTCTTTGTGGAAGCGCTCG) and one primer within the HIS3 fragment: either primer a (TTTCCCAGTCACGACGTTGT) or primer b (GAGTATACGTGATTAAGCAC) with 1 µl of a diluted 1/100 genomic DNA preparation as template in a 25-µl reaction. PCRs were run as follows: 94°/2 min, polymerase addition, and then 27 cycles of 94°/1 min, 57°/45 sec, 72°/1.5 min.
| RESULTS |
|---|
A genetic assay for detecting a compromised chromosomal cap:
To detect "uncapped" telomeres, we developed an assay based on the idea that an unprotected chromosome end would be vulnerable to recombination with an induced DSB end. The DSB is created in an artificial linear chromosome by an inducible HO endonuclease. On one side of the HO cleavage site are two selectable markers (URA3 and MET15), a centromere, and the only ARS (origin of replication) within the chromosome; on the other side is the HIS3 gene (Fig 1A and Fig B). After cleavage with HO, the HIS3 chromosomal fragment has a stable telomere on one end (the native end of the artificial chromosome) and the DSB end on the other. Because the HIS3 fragment lacks an ARS and is selected against rejoining with the other half of the artificial chromosome (Fig 1), the HIS3 fragment's only option for propagation is a capture event by a native chromosome. Only the DSB end of the HIS3 fragment is a substrate for a capture event because the opposite end is a telomere, and the rest of the HIS3 fragment lacks sequence homology with the yeast genome, which eliminates its opportunity for homologous recombination. Thus, the HIS3 fragment will most likely be captured by an unprotected native chromosome end.
By our definition, an unprotected chromosome end is susceptible to recombination events that we can detect by capture events in the assay. The capture events may be either sequence dependent or sequence independent. In the absence of telomerase in S. cerevisiae, telomeres and subtelomeric regions are maintained by homologous recombination (![]()
![]()
![]()
![]()
![]()
Therefore, to detect both homologous recombination and NHEJ at telomeres, two artificial chromosomes were created for use in the capping assay. Homologous recombination at telomeres is detected with an artificial chromosome that has a stretch of the TG13 sequence adjacent to the HO cleavage site (Fig 1A). This internal TG13 sequence tract is oriented so that it cannot act as a functional telomere, but it does have the potential to recombine with the telomeric DNA of a native chromosome end, thus allowing the HIS3 fragment to be captured by the end of a chromosome (Fig 1A). (This recombination event is technically homeologous because of the heterogeneous nature of the telomeric DNA repeats of S. cerevisiae, but for simplicity, we describe these events as homologous.) The other artificial chromosome has no homology to the rest of the genome, so that capture of the HIS3 chromosomal fragment will most likely be by NHEJ or end-to-end fusion (Fig 1B). Fusion events also can occur in the case of the artificial chromosome with the TG13 sequence tract (Fig 1A), but because the non-TG artificial chromosome cannot detect homologous recombination events, the combination of these two constructs allows us to evaluate the sequence dependency of the mechanism by which telomeres become compromised. Therefore, using both of the artificial chromosomes should permit detection of unprotected chromosome ends that succumb to either homologous recombination or NHEJ.
In a wild-type cell, telomeres are expected to be "uncapped" infrequently, if at all. Indeed, as measured in our assay, the capture of the HIS3 chromosomal fragment by homologous recombination or NHEJ occurred at a very low frequency in wild-type cells (Fig 1, Table 3), on the order of 10-8. These low frequencies suggested that telomeric ends are normally well protected against recombination.
During the development of the assay, we also examined the frequencies of capture of the HIS3 fragment without HO cleavage of the TG13-containing artificial chromosome. Because some of the mutant strains showed increased frequencies of telomeric capture after HO cleavage (described later), these data were compared to assays done without HO cleavage. In the absence of HO cleavage, there were fewer capture events, and the statistical distribution of the frequencies was broader than the distribution after HO cleavage (data not shown). This difference may be due to increased accessibility of the broken (HO-cut) end for recombination with a compromised telomeric end, which makes the capture of the HIS3 fragment a more reliable event. Alternatively, a compromised telomeric end may invade the TG13 tract on the artificial chromosome during growth of the culture and, via a nonreciprocal event, capture the HIS3 fragment. Either of these scenarios represents a sequence-dependent event at a compromised chromosome end and is discussed in the context of homologous recombination. The higher reproducibility (narrower distribution of frequencies) of the assay done in the presence of HO led us to use HO cleavage as part of all subsequent assays that are presented.
Different chromosome ends can become compromised:
To test whether the capture events in this genetic assay were truly indicative of capture at chromosome ends, we tested three predictions. First, to examine whether the HIS3 chromosomal fragment was physically linked to a native telomere after capture, a PCR-based method was designed. Because many chromosomes in S. cerevisiae have subtelomeric Y' elements that are conserved in sequence (![]()
![]()
10 to 300 bp (data not shown). These data indicate that virtually all of the homologous recombination capture events occurred at chromosome ends.
However, only
15% of NHEJ capture events in wild-type cells produced a PCR product indicative of capture at a Y'-associated chromosome end (data not shown). It was possible that a lack of PCR product was due to the loss of the primer sites on the HIS3 fragment by degradation from the HO end after cleavage. However, when different primers located within the HIS3 coding sequence (which must be present because of the His+ selection) were used, PCR products indicative of capture at a Y' telomere were still not detected in >80% of the NHEJ capture events. Thus the absence of PCR product may be due to attachment to a non-Y' telomere or to capture of the HIS3 fragment at a nontelomeric genomic location. As a result of the uncertainty in the precise genomic locations of these capture events, we have chosen not to use these results as true indicators of compromised telomeres. However, we do use the non-TG data to compare with the homologous recombination data set; it serves as a measure of "background" capture events in a particular strain.
Second, if any telomere can become compromised and lose its protective cap, then the capture events should be random, and the HIS3 fragment should be captured by any chromosome end. Examination of chromosomes by pulsed-field gel analysis revealed that the HIS3 gene was distributed among many different chromosomes in the various isolates (Fig 2D and data not shown; >200 isolates examined).
Third, because the capture events occurred on several different chromosome ends, we examined the "new telomere" of the native chromosome after the capture of the TG13-containing HIS3 fragment (Fig 2A). Indeed we found that all captured HIS3 fragments in >100 isolates had become the new chromosomal telomeres; when probed by Southern analysis, each isolate of a capture event produced a heterogeneous length band that is unique to telomeric DNA (data not shown). Similar analyses with NHEJ capture events also indicated that virtually all these HIS3 fragments had become the new telomeres.
Taken together, these data indicate that the assay using homologous recombination reliably detects capture events that occur at chromosome ends and that most, if not all, telomeric ends in the yeast genome can become compromised and participate in a capture event.
Cdc13p, Ku, and Stn1p protect the chromosome end:
The capping assay described above was applied to strains containing mutant versions of several genes that are associated with telomeres. The first set of genes included those encoding the telomeric DNA-binding proteins, Ku and Cdc13p, and the Cdc13p-associated protein, Stn1p. The yku70
, yku80
, cdc13-1, and stn1-13 strains showed dramatic increases in homologous recombination-based capture events at telomeres compared to wild-type cells (Fig 3A and Table 3). The yku70
, yku80
, and cdc13-1 mutations resulted in increases in the median frequencies of approximately three orders of magnitude over wild-type levels. By giving the cdc13-1 cells a 4-hr pulse at the restrictive temperature (30°), the frequency of homologous recombination at telomeres increased another 2-fold. Every isolate with one of these mutations (yku70
, yku80
, or cdc13-1) exhibited capture events in the assay. In contrast, at the permissive temperature (23°) the stn1-13 allele showed a small increase from wild-type levels, but 13% of the isolates exhibited no capture events. After a pulse at the restrictive temperature (37°), an increase in telomeric homologous recombination of >100-fold over wild-type levels was observed, and all isolates exhibited capture events. These data suggest that Ku and Cdc13p play roles in protecting the chromosome end. Stn1p plays a role as well, but it is unclear whether it is less important than its partner, Cdc13p, in capping the chromosome end or that the stn1-13 allele was not as penetrant as the yku
and cdc13-1 alleles in the assay.
These mutations also were assayed for their abilities to protect the telomeric end against NHEJ events. None of the single-mutant strains showed large increases in frequencies of NHEJ (Fig 3B and Table 2); most of the strains had frequencies within threefold of wild-type levels, although the cdc13-1 strain had an increase of approximately fivefold over wild type. Strains with yku
mutations showed a lower level of NHEJ events than did wild type, which likely reflects Ku's importance in NHEJ (reviewed in ![]()
Tel1 contributes to telomere protection, but shortened telomere length does not correlate with a loss of capping efficiency:
We next examined several telomere-associated mutations that affect the lengths of the telomeric DNA tracts. Like the yku
alleles, null mutations of MRE11, RAD50, and XRS2, whose gene products comprise the MRX nuclease complex (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
A tel1
mutation resulted in an increased frequency of capture via homologous recombination of
150-fold (Fig 3A and Table 3) but had little effect on NHEJ frequencies (Fig 3B and Table 3). In contrast, the null mutations of the MRX complex generated near-wild-type frequencies for homologous recombination (Fig 4A and Fig B, and Table 3). Because the capture events require recombination and the MRX genes are involved in recombination, it is possible that the mrx
mutations prevented the appearance of capture events. However, when combined with cdc13-1 and tel1
mutations that did increase the frequency of capture events, the double-mutant strains with mrx
mutations still led to increased frequencies (discussed later; Fig 4A and Table 3). These results suggest that TEL1 is critical to chromosomal cap integrity but that the MRX complex is not. Furthermore, although the yku
and tel1
mutations result in both short telomeres and an increased frequency of homologous recombination, the mrx
strains have short telomere repeat lengths yet retain their capping ability (Fig 4A and Fig B). Thus, a short average telomere length is not sufficient to compromise the chromosomal cap.
Two mutations with longer than normal telomeres, rif1
and rif2
, also were examined. Rif1p and Rif2p interact at telomeres with Rap1p, the essential DNA-binding protein, and all are required for the maintenance of normal telomere length (![]()
![]()
or rif2
strains by homologous recombination was not dramatically different from wild type (Fig 3A and Fig B, and Table 3). Curiously, there was an increase in these mutants in the NHEJ capture events. By the homologous recombination assay, cells with extended telomeric DNA tracts do not inherently have a problem in capping their chromosomes.
Telomeric silencing does not correlate with telomere capping:
The YKU genes are also required for transcriptional silencing of telomere-proximal genes (BOULTON and JACKSON 1998; ![]()
![]()
![]()
mutant strains lacked HML and HMR to avoid the potential complications of losing silencing at these loci: the increased availability of HO cut sites at HML and HMR (![]()
gene expression (![]()
![]()
Ku and Cdc13p define different telomere capping pathways:
Mutations in CDC13, YKU, and TEL1 created the most dramatic increases in frequencies of telomere capture events (Fig 3). To determine whether they acted in the same or different capping pathways, epistatic relationships among these genes were examined. In our strain background, the double-mutant combination of cdc13-1 yku
senesced
25 generations after sporulation, although infrequent survivors did arise in culture; these observations are consistent with growth defects reported previously for this mutant combination (![]()
![]()
The cdc13-1 tel1
strain showed high frequencies of telomeric capture by homologous recombination that were very similar to those of the cdc13-1 strain (Fig 3A and Table 3). In addition, there was no significant difference between the frequencies of capture events via NHEJ between cdc13-1 and cdc13-1 tel1
strains (Fig 3B and Table 3). Thus tel1
did not contribute any additional uncapping of telomeres in the cdc13-1 mutant strain, suggesting that Tel1p might normally affect telomere protection through Cdc13p.
In contrast, combinations of yku70
tel1
or yku80
tel1
showed the highest frequencies of telomeric capture via homologous recombination that were detected (Fig 3A and Table 3), and the frequencies were significantly higher than those of either of the single-mutant strains (P < 0.001 between yku
tel1
and yku
or tel1
). These double-mutant strains exhibited a modest increase in the frequencies of NHEJ compared to wild-type or single mutants (Fig 3B and Table 3). The synergistic effect of these mutations on telomeric homologous recombination suggests that Ku and Tel1p act via different pathways to cap the telomere.
The combinations of these double-mutant strains suggest that chromosomal caps are created from contributions of two genetic pathways, one mediated by CDC13 and the other by YKU. When both are compromised, telomeres are unstable and yield the lethal/senescent phenotype. Tel1p may act through the CDC13 pathway, perhaps modulating Cdc13p capping activity.
Further differences between compromised caps are revealed with recombination mutations:
The large increases in telomere capture events detected in cdc13-1, yku
, and tel1
mutations all occurred through the homologous recombination assay (Fig 3A and Table 3). However, we were curious whether there was a qualitative change in the cap for each mutant, which might then lead to distinct recombination pathways being used during a capture event. Therefore, using our capping assay with these three mutations, we tested the requirements for genetic pathways known to affect recombination at a DSB.
The first recombination component tested was Rad52p, a protein required for most homologous recombination in S. cerevisiae (![]()
, yku80
, cdc13-1, or tel1
mutations, resulted in significantly decreased frequencies of telomeric capture, although the frequencies were not reduced to wild-type levels (Fig 4A and Table 3; P < 0.001 for rad52 double-mutant vs. each single-mutant strain). The frequencies of NHEJ were not dramatically changed from the levels of wild-type or the single-mutant strains (Table 3; because all experiments examining NHEJ resulted in distributions that were similar to those seen in Fig 3B, analyses of NHEJ events in the mutant strains in Fig 4A are summarized only by the statistical data in Table 3). These results indicate that Rad52p contributes significantly, but not entirely, to the homologous recombination events at telomeres, as expected, but that another pathway is also involved.
Mutations in RAD1 were also examined. Rad1p binds Rad10p to form an endonuclease that cleaves the 3' single-stranded "flap" that is formed during recombination processing; the complex is required for some recombination events, such as single-stranded annealing, which occurs between repeated sequences (![]()
Rad51p is a homolog of the bacterial RecA protein; in S. cerevisiae, Rad51p initiates strand exchange after a double-stranded break and is required for some gene conversion events (![]()
![]()
mutations reveals a difference between the capping proteins: yku
rad51
and tel1
rad51
showed an increase in frequency of telomeric capture by homologous recombination over the single-mutant frequencies, whereas the frequencies for cdc13-1 rad51
decreased from the cdc13-1 levels (Fig 4A and Table 3; P < 0.001 for rad51
double-mutant vs. each single-mutant strain). The decrease in homologous recombination frequency observed in the cdc13-1 rad51
strain suggests that Rad51p is involved in the recombination events in cdc13-1 strains. In contrast, it appears that Rad51p was competing with, or otherwise inhibiting, a recombination mechanism in the yku
and tel1
strains (discussed later). Taken together with the single-mutant data, the chromosome ends seem qualitatively different among these three telomere-capping mutations.
Finally, we examined contributions by the MRX genes, which play a role in recombination as well as telomere length regulation (mentioned above). Sporulations of several different diploids revealed that the double- or triple-mutant combinations of yku
mrx
were senescent shortly after their creation (
25 generations; data not shown), although infrequent survivors did arise in the cultures. This effect is similar to the lethality observed with the yku
cdc13-1 strain (described above) and may reflect the contribution of the MRX complex to the loading of factors at the telomere (![]()
![]()
![]()
, tel1
, and mrx
were viable in our strain background, including our cdc13-1 mrx
strains. While not identical, these results are similar to previous observations in other strain backgrounds, where yku
mrx
strains showed a synthetic growth defect (![]()
![]()
strains were additionally temperature sensitive (![]()
The tel1
mrx
and cdc13-1 mrx
strains were then tested in the capping assay. The tel1
mrx
strains had a modest decrease in telomere capture frequency compared to the tel1
strain in the homologous recombination assay (Fig 4A and Table 3; P values vs. tel1
: P < 0.0001 for tel1
rad50
and tel1
xrs2
; P = 0.127 for tel1
mre11
). On the other hand, compared to cdc13-1 alone, the cdc13-1 mrx
combination showed no difference via homologous recombination (Fig 4A, Table 3; P value for the group = 0.249; P values vs. cdc13-1: P = 0.673 for cdc13-1 mre11
and cdc13-1
xrs2
; P = 0.075 for cdc13-1 rad50
). These results indicate that when Cdc13p is compromised, the MRX complex does not affect the protective cap nor the mechanism of capture via homologous recombination, but in the absence of Tel1p, the MRX complex seems to make a small contribution to the homologous recombination events. Thus, just as the analysis with rad51
revealed, combinations with rad50
(or mre11
or xrs2
) mutations suggest that telomeres are qualitatively different among yku
, tel1
, and cdc13-1 strains.
Telomere lengths of double-mutant strains do not correlate with telomere recombination:
We examined the telomere lengths of several double-mutant strains as another method to identify relationships among these telomere components (Fig 4B). As previously shown, telomeres of yku70
, tel1
, and mre11
strains have telomeric DNA repeats significantly shorter than those of wild type (![]()
![]()
![]()
tel1
and tel1
mre11
also have short telomeric repeats (![]()
and cdc13-1 tel1
strains show stable telomeric repeats of an intermediate length between the longer repeats of the cdc13-1 strain and the shorter ones of mrx
and tel1
strains (Fig 4B). These results are inconsistent with the similarities observed in the capping assay between the cdc13-1 single- and double-mutant strains (Fig 3A and Fig 4A); the cdc13-1 double-mutant strains show the same increased frequency of homologous recombination events as the cdc13-1 strains. These results provide additional evidence that telomere length does not correlate with capping efficiency.
| DISCUSSION |
|---|
We have developed a quantitative method to measure when a telomere becomes "uncapped." Because telomeric DNA is normally refractory to recombination, the assay was designed to detect rare events in which telomeric DNA is unprotected and can enter into DNA recombination events. We used the assay to determine whether a number of known telomeric components contributed to chromosomal capping. The assay revealed that the telomeric DNA-binding proteins Cdc13p and Ku provide protection against homologous recombination and that they define two pathways that are used to protect a chromosome end.
The protective role of Ku at telomeres appears to be evolutionarily conserved among eukaryotes. Ku was identified as a capping component in S. cerevisiae by the capping assay (Fig 3A) and in mammals by immunofluorescence microscopy (![]()
![]()
![]()
![]()
![]()
These opposing actions may reflect regulation of Ku that may occur as a result of cell cycle timing, competition with other capping activities, alternative binding partnerseither DNA (blunt ends, single stranded, etc.) or protein (e.g., Taz1 or the DNA-dependent protein kinase)or perhaps species-specific differences. Alternatively, Ku may change the telomeric structure, perhaps in preventing the formation of a single-stranded overhang (discussed later), so that the absence of Ku enables homologous recombination at telomeres. This latter idea is consistent with the capping assay, which revealed that telomeric homologous recombination events increased in yku
strains, and NHEJ events were unaffected. Because the assay provides a recombination substrate for both homologous and NHEJ events, this difference could be detected, whereas immunofluorescence studies do not distinguish between these events; the absence of Ku may stimulate homologous events at mammalian telomeres as well. Another possibility is that the presence of telomerase inhibits NHEJ events at the telomere, whether or not Ku is present. The deletion of EST1, a telomerase-associated component, led to end-to-end fusion events in S. cerevisiae (![]()
Our assay also showed that Cdc13p, a telomeric DNA-binding protein, protects against homologous recombination at telomeres (Fig 3A). The cdc13-1 strain was defective in protection at the permissive temperature (23°), and the defect was enhanced after a pulse at 30°. Our results are in agreement with earlier characterization of the cdc13-1 mutation, which showed that it had higher levels of mitotic recombination near telomeres (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
The TEL1 gene, an ATM kinase homolog, also had a pronounced effect on capping the telomere (Fig 3). Tel1p's role in protection is likely regulatory, acting, at least in part, through Cdc13p. Our epistasis analysis revealed that a cdc13-1 tel1
strain exhibits a similar median telomeric homologous recombination frequency <